Literature DB >> 17697870

Acceleration of diabetic renal injury in the superoxide dismutase knockout mouse: effects of tempol.

Frederick R DeRubertis1, Patricia A Craven, Mona F Melhem.   

Abstract

Indices of renal injury and oxidative stress were examined in mice with deficiency of cytosolic Cu(2+)/Zn(2+) superoxide dismutase (SOD1-/-, KO) and their wild-type (WT) littermates with streptozotocin-induced diabetes. After 5 weeks of diabetes, KO diabetic (D) but not WT-D mice developed marked albuminuria, increases in glomerular content of transforming growth factor beta, collagen alpha1(IV), and nitrotyrosine, and higher glomerular superoxide compared with corresponding values in nondiabetics. After 5 months of diabetes, increases in these parameters, mesangial matrix expansion, renal cortical malondialdehyde content, and severity of tubulointerstitial injury were all significantly greater, whereas cortical glutathione was lower, in KO-D than in WT-D. In contrast to WT-D, after 4 weeks of diabetes, KO-D mice did not develop the increase in inulin clearance (C(In)) characteristic of early diabetes. The nitric oxide synthase inhibitor N(omega)-nitro-l-arginine methylester suppressed C(In) in WT-D, but had no effect on C(In) in KO-D. Treatment of KO-D with the SOD mimetic tempol for 4 weeks suppressed albuminuria, increases in glomerular transforming growth factor beta, collagen alpha1(IV), nitrotyrosine, and glomerular superoxide, and concurrently increased C(In). The latter action of tempol in KO-D was blocked by the N(omega)-nitro-l-arginine methylester. The findings provide support for a role for superoxide and its metabolism by SOD1 in the pathogenesis of renal injury in diabetes in vivo, and implicate increased interaction of superoxide with nitric oxide as a pathogenetic factor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17697870     DOI: 10.1016/j.metabol.2007.04.024

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  29 in total

Review 1.  Oxidative stress and diabetic complications.

Authors:  Ferdinando Giacco; Michael Brownlee
Journal:  Circ Res       Date:  2010-10-29       Impact factor: 17.367

2.  Extracellular Superoxide Dismutase Protects against Proteinuric Kidney Disease.

Authors:  Roderick J Tan; Dong Zhou; Liangxiang Xiao; Lili Zhou; Yingjian Li; Sheldon I Bastacky; Tim D Oury; Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2015-02-02       Impact factor: 10.121

3.  The synthetic genetic interaction network reveals small molecules that target specific pathways in Sacchromyces cerevisiae.

Authors:  Craig M Tamble; Robert P St Onge; Guri Giaever; Corey Nislow; Alexander G Williams; Joshua M Stuart; R Scott Lokey
Journal:  Mol Biosyst       Date:  2011-04-12

4.  MicroRNA-21 orchestrates high glucose-induced signals to TOR complex 1, resulting in renal cell pathology in diabetes.

Authors:  Nirmalya Dey; Falguni Das; Meenalakshmi M Mariappan; Chandi Charan Mandal; Nandini Ghosh-Choudhury; Balakuntalam S Kasinath; Goutam Ghosh Choudhury
Journal:  J Biol Chem       Date:  2011-05-25       Impact factor: 5.157

Review 5.  Oxidative stress and diabetes: what can we learn about insulin resistance from antioxidant mutant mouse models?

Authors:  Jennalynn Styskal; Holly Van Remmen; Arlan Richardson; Adam B Salmon
Journal:  Free Radic Biol Med       Date:  2011-10-20       Impact factor: 7.376

6.  AMP-activated protein kinase (AMPK) negatively regulates Nox4-dependent activation of p53 and epithelial cell apoptosis in diabetes.

Authors:  Assaad A Eid; Bridget M Ford; Karen Block; Balakuntalam S Kasinath; Yves Gorin; Goutam Ghosh-Choudhury; Jeffrey L Barnes; Hanna E Abboud
Journal:  J Biol Chem       Date:  2010-09-22       Impact factor: 5.157

Review 7.  Nox4 and diabetic nephropathy: with a friend like this, who needs enemies?

Authors:  Yves Gorin; Karen Block
Journal:  Free Radic Biol Med       Date:  2013-03-23       Impact factor: 7.376

8.  Literature-based discovery of diabetes- and ROS-related targets.

Authors:  Junguk Hur; Kelli A Sullivan; Adam D Schuyler; Yu Hong; Manjusha Pande; David J States; H V Jagadish; Eva L Feldman
Journal:  BMC Med Genomics       Date:  2010-10-27       Impact factor: 3.063

9.  Poly(ADP-ribose) polymerase (PARP) inhibition counteracts multiple manifestations of kidney disease in long-term streptozotocin-diabetic rat model.

Authors:  Hanna Shevalye; Roman Stavniichuk; Weizheng Xu; Jie Zhang; Sergey Lupachyk; Yury Maksimchyk; Viktor R Drel; Elizabeth Z Floyd; Barbara Slusher; Irina G Obrosova
Journal:  Biochem Pharmacol       Date:  2009-11-27       Impact factor: 5.858

10.  Multiple superoxide dismutase 1/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Genetics study.

Authors:  Hussam Al-Kateb; Andrew P Boright; Lucia Mirea; Xinlei Xie; Rinku Sutradhar; Alireza Mowjoodi; Bhupinder Bharaj; Michelle Liu; Jean M Bucksa; Valerie L Arends; Michael W Steffes; Patricia A Cleary; Wanjie Sun; John M Lachin; Paul S Thorner; Michael Ho; Amy Jayne McKnight; A Peter Maxwell; David A Savage; Kenneth K Kidd; Judith R Kidd; William C Speed; Trevor J Orchard; Rachel G Miller; Lei Sun; Shelley B Bull; Andrew D Paterson
Journal:  Diabetes       Date:  2007-10-03       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.